Products & Services · Total Revenue

Product revenue, net — Total Revenue

Biogen Product revenue, net — Total Revenue increased by 5.1% to $1.75B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $1.73B to $1.75B. Over 4 years (FY 2021 to FY 2025), Product revenue, net — Total Revenue shows a downward trend with a -5.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful market penetration, strong demand for the product portfolio, or effective pricing strategies, while a decrease may signal loss of market share, patent expirations, or increased competition.

Detailed definition

This metric represents the total net sales generated from the company's portfolio of pharmaceutical products after accou...

Peer comparison

Comparable to 'Net Product Sales' or 'Total Revenue from Pharmaceutical Products' reported by other large-cap biotechnology and pharmaceutical firms.

Metric ID: biib_segment_product_revenue_net_total_revenue

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.24B$2.21B$2.19B$2.07B$2.05B$1.96B$1.90B$1.76B$1.85B$1.81B$1.83B$1.71B$1.90B$1.77B$1.83B$1.73B$1.88B$1.85B$1.67B$1.75B
QoQ Change-1.4%-0.6%-5.8%-0.6%-4.5%-2.9%-7.4%+4.7%-2.2%+1.5%-6.6%+11.0%-6.9%+3.6%-5.8%+8.8%-1.7%-9.7%+5.1%
YoY Change-8.1%-11.0%-13.2%-14.7%-10.2%-8.0%-3.8%-2.9%+2.9%-2.0%+0.0%+0.9%-1.1%+4.4%-9.0%+1.5%
Range$1.67B$2.24B
CAGR-5.0%
Avg YoY Growth-4.6%
Median YoY Growth-3.4%

Frequently Asked Questions

What is Biogen's product revenue, net — total revenue?
Biogen (BIIB) reported product revenue, net — total revenue of $1.75B in Q1 2026.
How has Biogen's product revenue, net — total revenue changed year-over-year?
Biogen's product revenue, net — total revenue increased by 1.5% year-over-year, from $1.73B to $1.75B.
What is the long-term trend for Biogen's product revenue, net — total revenue?
Over 4 years (2021 to 2025), Biogen's product revenue, net — total revenue has grown at a -5.3% compound annual growth rate (CAGR), from $8.85B to $7.12B.
What does product revenue, net — total revenue mean?
The total amount of money earned from selling the company's pharmaceutical products after all sales adjustments.